RPS10 antibodies target the 40S ribosomal protein S10, a critical component of ribosome biogenesis and protein synthesis. These antibodies are widely used to study ribosomal dysfunction in diseases like cancer, Diamond-Blackfan anemia (DBA9), and neurodegenerative disorders .
RPS10 overexpression correlates with tumor progression in gastric carcinoma and triple-negative breast cancer .
Antibodies like ab151550 detect RPS10 in lymphoma (Raji cells) and leukemia (K-562) lysates via WB, showing differential expression in malignant vs. normal tissues .
PRMT5-mediated methylation at Arg158/Arg160 stabilizes RPS10 and ensures its localization to nucleolar granular components. Mutations at these sites disrupt ribosome assembly and promote proteasomal degradation .
Anti-RPS10 antibodies (e.g., SYM11) validate interactions with nucleophosmin/B23, critical for ribosome maturation .
Diamond-Blackfan Anemia (DBA9): RPS10 mutations linked to DBA9 are detectable using antibodies like PA5-96460, which target conserved epitopes across species .
Neurodegeneration: Dysregulated RPS10 expression in Alzheimer’s models is quantifiable via ELISA using polyclonal CAB6056 .
| Cell Line | Observed Band (kDa) | Antibody Used |
|---|---|---|
| HeLa | 19 | ab151550 |
| Raji | 19 | 14894-1-AP |
| NIH/3T3 (Mouse) | 19 | 67609-1-Ig |
Human Pancreas/Gastric Carcinoma: ab151550 shows strong nuclear/cytoplasmic staining at 1:100 dilution using Tris-EDTA antigen retrieval .
Mouse Spleen/Liver: PA5-96460 confirms RPS10 localization in nucleoli and cytoplasm .
RPS10 (Ribosomal Protein S10) is a component of the 40S ribosomal subunit involved in protein synthesis. This approximately 19 kDa protein plays essential roles in ribosome assembly and translation regulation . Research interest in RPS10 has increased due to its involvement in various cellular processes beyond protein synthesis, including potential roles in cell signaling, stress response, and disease pathogenesis. Studying RPS10 using specific antibodies provides insights into fundamental cellular functions and potential biomarker applications in various physiological and pathological conditions .
RPS10 antibodies can be employed across multiple experimental platforms with specific dilution recommendations:
| Application | Compatible | Recommended Dilution | Sample Types |
|---|---|---|---|
| Western Blot (WB) | Yes | 1:1000-1:2000 | Cell lysates, tissue homogenates |
| Immunohistochemistry (IHC) | Yes | Application-dependent | FFPE tissue sections |
| Immunofluorescence (IF) | Yes | Application-dependent | Cultured cells, tissue sections |
| Immunoprecipitation (IP) | Yes | Application-dependent | Cell lysates |
| ELISA | Yes | Application-dependent | Purified proteins |
Optimal dilutions should be determined experimentally for each application and sample type. Multiple validation studies confirm reactivity with human, mouse, and rat samples .
For rigorous experimental design, include the following controls:
Positive controls: Well-characterized cell lines with known RPS10 expression (HepG2, Jurkat, K-562, HSC-T6, NIH/3T3)
Negative controls:
Primary antibody omission control
Isotype control (using matched IgG at the same concentration)
Blocking peptide competition assay to confirm specificity
Loading controls: For WB applications, include housekeeping proteins such as β-Tubulin, GAPDH, or Lamin B depending on your experimental context
Appropriate controls ensure result validity and help troubleshoot potential experimental issues.
RPS10 undergoes various post-translational modifications, most notably arginine methylation at residues Arg158 and Arg160 by Protein-arginine Methyltransferase 5 (PRMT5) . To investigate these modifications:
| Modification | Detection Method | Required Materials | Considerations |
|---|---|---|---|
| Arginine Methylation | Western blot | Anti-methylarginine antibody (SYM11) | Can be used alongside RPS10 antibodies in sequential blotting |
| Phosphorylation | Phospho-specific antibodies | Commercially unavailable; custom antibodies may be needed | Phosphatase inhibitors essential during extraction |
| Ubiquitination | Co-IP followed by ubiquitin detection | Anti-ubiquitin antibodies | Proteasome inhibitors (MG132) required during sample preparation |
For arginine methylation studies, researchers should consider using cycloheximide (CHX) chase experiments (100 μg/ml) with or without proteasome inhibitors (10 μM MG132) to assess protein stability and turnover .
Optimized extraction protocols significantly impact RPS10 antibody performance. For ribosomal proteins like RPS10, consider:
Standard cell lysis buffer components:
50 mM Tris-HCl (pH 7.4)
150 mM NaCl
1% Triton X-100
0.5% sodium deoxycholate
Protease inhibitor cocktail
Phosphatase inhibitors
Subcellular fractionation:
For nucleolar enrichment (where ribosome biogenesis occurs)
For cytoplasmic isolation (mature ribosomes)
Polysome profiling:
For studying RPS10 in actively translating ribosomes
Requires sucrose gradient centrifugation
Avoid repeated freeze-thaw cycles as this can degrade ribosomal proteins. For optimal results, process samples immediately after collection or store at -80°C with appropriate protease inhibitors .
Distinguishing RPS10 variants requires strategic experimental approaches:
Site-directed mutagenesis controls:
Epitope mapping:
Mass spectrometry validation:
For definitive identification of specific variants and their modifications
Can be combined with immunoprecipitation using RPS10 antibodies
These approaches are particularly important when studying disease-associated RPS10 variants or investigating isoform-specific functions.
Non-specific binding is a common challenge when working with ribosomal protein antibodies due to their abundance and structural similarities:
| Issue | Optimization Strategy | Technical Details |
|---|---|---|
| Multiple bands | Titrate antibody concentration | Test dilutions from 1:500 to 1:5000 to identify optimal signal-to-noise ratio |
| Background smearing | Optimize blocking conditions | Try 5% non-fat milk vs. 3-5% BSA; consider extending blocking time to 2 hours |
| Cross-reactivity | Increase washing stringency | Use TBST with 0.1-0.3% Tween-20; increase wash duration and number of washes |
| High background | Reduce exposure time | For chemiluminescence detection, start with short exposures (5-30 seconds) |
| Inconsistent loading | Normalize to housekeeping proteins | β-Tubulin, GAPDH, or Lamin B depending on experimental context |
For particularly challenging samples, pre-adsorption of the antibody with non-relevant tissues or proteins can reduce non-specific binding. The purity of commercially available RPS10 antibodies is typically >95% by SDS-PAGE, which should minimize non-specific binding when used at recommended dilutions .
Immunoprecipitation of RPS10 requires attention to the following factors:
Antibody selection:
Lysis conditions:
Use mild detergents (0.5% NP-40 or 1% Triton X-100)
Include RNase inhibitors if studying RPS10-RNA interactions
Maintain physiological salt concentration (150 mM NaCl) to preserve protein-protein interactions
Bead selection:
Controls:
IgG control from the same species as the RPS10 antibody
Input sample (5-10% of lysate used for IP)
Beads-only control to identify non-specific binding
For co-immunoprecipitation studies investigating RPS10 interaction partners, crosslinking with formaldehyde (1% for 10 minutes) may help preserve transient interactions.
Cross-species reactivity varies among commercial RPS10 antibodies:
| Species | Reactivity Level | Validation Methods | Considerations |
|---|---|---|---|
| Human | High | WB, IHC, IF, IP | Most extensively validated |
| Mouse | Moderate to High | WB, IHC, IF | Confirmed in multiple cell lines (e.g., NIH/3T3) |
| Rat | Moderate to High | WB, IHC | Confirmed in select cell lines (e.g., HSC-T6) |
| Other mammals | Variable | Limited validation | Sequence homology prediction required |
| Non-mammalian | Limited | Rarely tested | Not recommended without validation |
When working with non-validated species, perform preliminary testing using positive control samples. RPS10 is highly conserved across species, but epitope accessibility may differ due to species-specific post-translational modifications or protein interactions .
RPS10 antibodies provide valuable tools for investigating ribosome assembly and biogenesis:
Nucleolar stress analysis:
Use IF to monitor RPS10 subcellular localization
Under nucleolar stress, patterns of RPS10 distribution between nucleolus, nucleoplasm, and cytoplasm change
Co-staining with nucleolar markers (fibrillarin, nucleolin) provides context
Pre-ribosomal particle analysis:
Sucrose gradient centrifugation followed by fraction collection
Western blot analysis of fractions using RPS10 antibodies
Altered RPS10 distribution across fractions indicates assembly defects
Pulse-chase experiments:
These approaches are particularly valuable for studying ribosomopathies and cancer-related ribosome biogenesis alterations.
RPS10 methylation has significant functional consequences:
Stability regulation:
Functional effects:
Influences ribosome assembly and translation efficiency
May affect recruitment of specific mRNAs to ribosomes
Can alter interactions with translation factors
Detection methods:
Understanding these modifications provides insights into how post-translational regulation of ribosomal proteins contributes to specialized translation programs in development and disease.
RPS10 has emerging relevance in cancer biology through several mechanisms:
Altered expression patterns:
Use RPS10 antibodies for expression profiling across cancer tissues
Compare with matched normal tissues using IHC or tissue microarrays
Correlate expression with clinical outcomes
Specialized translation programs:
Investigate RPS10's role in cancer-specific mRNA translation
Combine with RNA-sequencing after RPS10 immunoprecipitation
Analyze changes in translational efficiency of oncogenes or tumor suppressors
Stress response markers:
Monitor RPS10 localization during genotoxic or ribosomal stress
Evaluate as a potential biomarker for treatment response
The established applications of RPS10 antibodies in WB, IHC, and IF make them valuable tools for these investigations across human tumor samples and cancer cell lines .
Super-resolution microscopy with RPS10 antibodies requires specific optimizations:
Antibody selection:
Primary antibodies with high specificity are essential
Secondary antibody quality critically impacts resolution
Consider directly conjugated primaries for STORM/PALM techniques
Sample preparation:
Fixation method affects epitope accessibility (4% PFA recommended)
Permeabilization conditions influence antibody penetration
Blocking must be thorough but preserve structural integrity
Technical considerations:
Validate antibody specificity before super-resolution applications
Appropriate controls must account for potential nanoscale artifacts
Consider established ribosomal markers for co-localization studies
Super-resolution microscopy can reveal the nanoscale organization of ribosomes in different cellular compartments and under various stress conditions, offering insights not possible with conventional microscopy.